Clinical Trial Update: Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing hypertonic sodium lactate solution with 6% hydroxyethyl starch in coronary artery bypass grafting patients assessed efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Hydroxyethyl starch 6% solution (hydroxyethyl starch)
• Hypertonic sodium lactate solution (sodium lactate solution, hypertonic)

Snippet

Sponsor: Innogene Kalbiotech Pte. Ltd | Conditions: Coronary Heart Disease | Phase 4 | Status: COMPLETED